iStent inject

DEVICE4 trials

Sponsors

Glaukos Corporation, Sight Sciences, Inc.

Conditions

Glaucoma, Open-AngleOpen-angle GlaucomaPrimary Open-angle Glaucoma

Phase 4

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost

CompletedNCT01444040

Glaukos CorporationOpen-angle Glaucoma

Start: 2011-09-30End: 2019-03-28Updated: 2022-09-08

Unknown Phase

Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery

CompletedNCT01461291

Glaukos CorporationPrimary Open-angle Glaucoma

Start: 2012-01-16End: 2018-10-31Updated: 2022-05-19

A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma

TerminatedNCT04616573

Sight Sciences, Inc.Glaucoma, Open-Angle

Start: 2020-11-13End: 2021-01-20Updated: 2022-12-01

Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)

TerminatedNCT04658095

Sight Sciences, Inc.Glaucoma, Open-Angle

Start: 2022-01-11End: 2022-11-18Updated: 2025-10-27